Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Laboratorios Litaphar

Laboratorios Litaphar
2001 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer and distributor of genetic and therapeutic pharmaceutical products designed to provide therapeutic products for illnesses related to women. The company's genetic and therapeutic pharmaceutical products provide cure of diseases related to gynecology and obstetrics of prostaglandin analogues, progesterone receptor antagonists and selective modulators of progesterone receptors, enabling women patients to recover from illness and improve their sexuality and vulvar health.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • Loiolabide, 7
  • 20730 Azpeitia
  • Spain

+34 943 00 00 00

Laboratorios Litaphar Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Laboratorios Litaphar‘s full profile, request access.

Request full access to PitchBook

Laboratorios Litaphar Executive Team (1)

Name Title Board
Seat
Contact
Info
Ander LarraƱaga General Manager, Business Development